Myoclonic Epilepsy Beginning in Infancy or Early Childhood Workup
- Author: Michael C Kruer, MD; Chief Editor: Amy Kao, MD more...
Approach Considerations
EEG is the centerpiece of the diagnostic evaluation. If neuroimaging is performed, magnetic resonance imaging is preferred. Results are often normal, reflecting a genetic rather than structural etiology, although congenital brain abnormalities sometimes are observed. In some forms of childhood myoclonic epilepsy, progressive cortical atrophy may be seen.
Electroencephalography
The ictal EEG correlate of myoclonic seizures consists of fast spike-wave discharges (>2.5 Hz), which, at times, are associated with slower 2- to 2.5-Hz discharges.[9] Interictal recordings may be normal or show slowing, depending on the etiology. Like other generalized epilepsies, abnormalities are frequently seen on routine EEG, even if myoclonus is not captured.
Brief (< 3 seconds) interictal bursts of irregular polyspike-waves may be seen either spontaneously or with photic stimulation. The occurrence of these discharges is increased during non–rapid eye movement (REM) sleep.
Also see EEG in Common Epilepsy Syndromes, EEG Video Monitoring, and Generalized Epilepsies on EEG.
Additional Testing
Genetic tests
In select cases, testing for SCN1A or other genetic etiologies suggested by clinical history and/or examination may be appropriate.
Lumbar puncture
Lumbar puncture may be helpful in identifying mitochondrial disorders (elevated cerebrospinal fluid [CSF] lactate) or nonketotic hyperglycinemia (elevated CSF glycine). Elevated protein may indicate a neurodegenerative disease.
Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. Apr 2010;51(4):676-85. [Medline].
Djukic A, Lado FA, Shinnar S, Moshé SL. Are early myoclonic encephalopathy (EME) and the Ohtahara syndrome (EIEE) independent of each other?. Epilepsy Res. Aug 2006;70 Suppl 1:S68-76. [Medline].
Kelley SA, Kossoff EH. Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress. Dev Med Child Neurol. Nov 2010;52(11):988-93. [Medline].
Dravet C. The core Dravet syndrome phenotype. Epilepsia. Apr 2011;52 Suppl 2:3-9. [Medline].
Michoulas A, Farrell K. Medical management of Lennox-Gastaut syndrome. CNS Drugs. May 1 2010;24(5):363-74. [Medline].
Shahwan A, Farrell M, Delanty N. Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects. Lancet Neurol. Apr 2005;4(4):239-48. [Medline].
Cohen BH, Chinnery PF, Copeland WC. POLG-Related Disorders. In: Pagon RA, Bird TD, Dolan CR, Stephens K, eds. GeneReviews [Internet]. University of Washington, Seattle; 1993-2010 Mar 16.
Crompton DE, Berkovic SF. The borderland of epilepsy: clinical and molecular features of phenomena that mimic epileptic seizures. Lancet Neurol. Apr 2009;8(4):370-81. [Medline].
Korff CM, Nordli DR Jr. Epilepsy syndromes in infancy. Pediatr Neurol. Apr 2006;34(4):253-63. [Medline].
Wallace SJ. Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide. Epilepsy Res. Jan 1998;29(2):147-54. [Medline].
Andrade DM, Hamani C, Minassian BA. Treatment options for epileptic myoclonus and epilepsy syndromes associated with myoclonus. Expert Opin Pharmacother. Jul 2009;10(10):1549-60. [Medline].
Wheless JW, Sankar R. Treatment strategies for myoclonic seizures and epilepsy syndromes with myoclonic seizures. Epilepsia. 2003;44 Suppl 11:27-37. [Medline].

